Loss of BAP1 is associated with worse patient survival in ccRCC and seems to be mutually exclusive withPBRM1 mutations (Joseph et al., 2014; Joseph et al., 2016). The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.